Annual CFF
$73.10 K
+$1.84 M+104.13%
31 December 2023
Summary:
China Pharma Holdings annual cash flow from financing activities is currently $73.10 thousand, with the most recent change of +$1.84 million (+104.13%) on 31 December 2023. During the last 3 years, it has fallen by -$551.10 thousand (-88.29%). CPHI annual CFF is now -99.41% below its all-time high of $12.32 million, reached on 31 December 2013.CPHI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$6800.00
-$100.00-1.45%
30 September 2024
Summary:
China Pharma Holdings quarterly cash flow from financing activities is currently $6800.00, with the most recent change of -$100.00 (-1.45%) on 30 September 2024. Over the past year, it has increased by +$483.20 thousand (+101.43%). CPHI quarterly CFF is now -99.93% below its all-time high of $9.26 million, reached on 30 June 2008.CPHI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$51.00 K
+$483.20 K+111.80%
30 September 2024
Summary:
China Pharma Holdings TTM cash flow from financing activities is currently $51.00 thousand, with the most recent change of +$483.20 thousand (+111.80%) on 30 September 2024. Over the past year, it has increased by +$680.40 thousand (+108.10%). CPHI TTM CFF is now -99.61% below its all-time high of $12.93 million, reached on 31 March 2014.CPHI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +104.1% | +101.4% | +108.1% |
| 3 y3 years | -88.3% | +101.6% | +257.4% |
| 5 y5 years | +103.7% | +100.5% | +103.7% |
CPHI Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -98.4% | +104.1% | -99.8% | +100.8% | -98.9% | +102.9% |
| 5 y | 5 years | -98.4% | +103.7% | -99.8% | +100.5% | -98.9% | +102.9% |
| alltime | all time | -99.4% | +101.2% | -99.9% | +100.2% | -99.6% | +100.8% |
China Pharma Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6800.00(-1.4%) | $51.00 K(-111.8%) |
| June 2024 | - | $6900.00(0.0%) | -$432.20 K(-1.4%) |
| Mar 2024 | - | $6900.00(-77.3%) | -$438.20 K(-699.5%) |
| Dec 2023 | $73.10 K(-104.1%) | $30.40 K(-106.4%) | $73.10 K(-111.6%) |
| Sept 2023 | - | -$476.40 K(<-9900.0%) | -$629.40 K(+405.1%) |
| June 2023 | - | $900.00(-99.8%) | -$124.60 K(-87.2%) |
| Mar 2023 | - | $518.20 K(-177.1%) | -$976.10 K(-44.9%) |
| Dec 2022 | -$1.77 M(-138.5%) | -$672.10 K(-2466.5%) | -$1.77 M(-150.3%) |
| Sept 2022 | - | $28.40 K(-103.3%) | $3.52 M(+14.8%) |
| June 2022 | - | -$850.60 K(+208.4%) | $3.07 M(-31.3%) |
| Mar 2022 | - | -$275.80 K(-106.0%) | $4.47 M(-2.8%) |
| Dec 2021 | $4.60 M(+636.6%) | $4.62 M(-1186.8%) | $4.60 M(<-9900.0%) |
| Sept 2021 | - | -$425.10 K(-177.6%) | -$32.40 K(-96.1%) |
| June 2021 | - | $548.00 K(-477.4%) | -$841.20 K(-243.5%) |
| Mar 2021 | - | -$145.20 K(+1337.6%) | $586.00 K(-6.1%) |
| Dec 2020 | $624.20 K(-136.1%) | -$10.10 K(-99.2%) | $624.20 K(-0.8%) |
| Sept 2020 | - | -$1.23 M(-162.5%) | $629.30 K(+21.5%) |
| June 2020 | - | $1.98 M(-1946.0%) | $518.10 K(-133.0%) |
| Mar 2020 | - | -$107.00 K(+2040.0%) | -$1.57 M(-9.3%) |
| Dec 2019 | -$1.73 M(-12.5%) | -$5000.00(-99.6%) | -$1.73 M(+23.8%) |
| Sept 2019 | - | -$1.35 M(+1112.9%) | -$1.40 M(-36.5%) |
| June 2019 | - | -$110.90 K(-58.6%) | -$2.20 M(+5.3%) |
| Mar 2019 | - | -$267.80 K(-181.9%) | -$2.09 M(+5.6%) |
| Dec 2018 | -$1.98 M(+33.6%) | $327.00 K(-115.2%) | -$1.98 M(-14.6%) |
| Sept 2018 | - | -$2.15 M(<-9900.0%) | -$2.31 M(+55.2%) |
| June 2018 | - | $200.00(-100.1%) | -$1.49 M(-0.1%) |
| Mar 2018 | - | -$157.30 K(+1384.0%) | -$1.49 M(+0.8%) |
| Dec 2017 | -$1.48 M(-75.4%) | -$10.60 K(-99.2%) | -$1.48 M(-59.9%) |
| Sept 2017 | - | -$1.32 M(>+9900.0%) | -$3.69 M(-37.0%) |
| June 2017 | - | -$600.00(-99.6%) | -$5.86 M(+0.0%) |
| Mar 2017 | - | -$145.20 K(-93.5%) | -$5.86 M(-2.7%) |
| Dec 2016 | -$6.02 M(<-9900.0%) | -$2.22 M(-36.4%) | -$6.02 M(+58.5%) |
| Sept 2016 | - | -$3.49 M(>+9900.0%) | -$3.80 M(+1141.8%) |
| June 2016 | - | -$200.00(-99.9%) | -$306.00 K(+0.1%) |
| Mar 2016 | - | -$305.80 K(<-9900.0%) | -$305.80 K(<-9900.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| June 2015 | - | $0.00(0.0%) | -$400.00(-85.7%) |
| Mar 2015 | - | $0.00(-100.0%) | -$2800.00(-100.5%) |
| Dec 2014 | $605.00 K(-95.1%) | $200.00(-133.3%) | $604.90 K(-90.7%) |
| Sept 2014 | - | -$600.00(-75.0%) | $6.49 M(-49.8%) |
| June 2014 | - | -$2400.00(-100.4%) | $12.93 M(-0.0%) |
| Mar 2014 | - | $607.70 K(-89.7%) | $12.93 M(+4.9%) |
| Dec 2013 | $12.32 M(+858.1%) | $5.88 M(-8.6%) | $12.32 M(+68.1%) |
| Sept 2013 | - | $6.44 M(>+9900.0%) | $7.33 M(+638.1%) |
| June 2013 | - | $0.00(0.0%) | $993.20 K(-22.8%) |
| Mar 2013 | - | $0.00(-100.0%) | $1.29 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $1.29 M(+115.9%) | $893.20 K(+793.2%) | $1.29 M(+100.7%) |
| Sept 2012 | - | $100.00 K(-65.9%) | $640.80 K(-8.6%) |
| June 2012 | - | $293.00 K(>+9900.0%) | $700.80 K(+32.8%) |
| Mar 2012 | - | $0.00(-100.0%) | $527.80 K(-11.4%) |
| Dec 2011 | $595.70 K(-77.6%) | $247.80 K(+54.9%) | $595.70 K(-44.9%) |
| Sept 2011 | - | $160.00 K(+33.3%) | $1.08 M(+302.8%) |
| June 2011 | - | $120.00 K(+76.7%) | $268.30 K(+80.9%) |
| Mar 2011 | - | $67.90 K(-90.7%) | $148.30 K(-94.4%) |
| Dec 2010 | $2.66 M(+92.2%) | $732.70 K(-212.3%) | $2.66 M(+33.1%) |
| Sept 2010 | - | -$652.30 K(<-9900.0%) | $2.00 M(-49.6%) |
| June 2010 | - | $0.00(-100.0%) | $3.97 M(0.0%) |
| Mar 2010 | - | $2.58 M(+3574.3%) | $3.97 M(+186.4%) |
| Dec 2009 | $1.39 M(-84.4%) | $70.30 K(-94.7%) | $1.39 M(-63.0%) |
| Sept 2009 | - | $1.32 M(>+9900.0%) | $3.74 M(<-9900.0%) |
| June 2009 | - | $0.00(0.0%) | -$6100.00(-100.1%) |
| Mar 2009 | - | $0.00(-100.0%) | $9.26 M(+4.2%) |
| Dec 2008 | $8.88 M(-4474.9%) | $2.43 M(-199.7%) | $8.88 M(+261.9%) |
| Sept 2008 | - | -$2.43 M(-126.3%) | $2.45 M(-49.8%) |
| June 2008 | - | $9.26 M(-2561.7%) | $4.89 M(-215.3%) |
| Mar 2008 | - | -$376.30 K(-90.6%) | -$4.24 M(+1987.5%) |
| Dec 2007 | -$203.00 K(-109.6%) | -$4.00 M(<-9900.0%) | -$203.00 K(-105.4%) |
| Sept 2007 | - | $0.00(-100.0%) | $3.78 M(-35.9%) |
| June 2007 | - | $138.90 K(-96.2%) | $5.90 M(+2.4%) |
| Mar 2007 | - | $3.66 M(<-9900.0%) | $5.76 M(+173.7%) |
| Dec 2006 | $2.11 M(+68.6%) | -$14.70 K(-100.7%) | $2.11 M(-0.7%) |
| Sept 2006 | - | $2.12 M(>+9900.0%) | $2.12 M(-38.4%) |
| June 2006 | - | $0.00(0.0%) | $3.44 M(-5.5%) |
| Mar 2006 | - | $0.00(-100.0%) | $3.64 M(0.0%) |
| Dec 2005 | $1.25 M(+524.4%) | - | - |
| Sept 2005 | - | $3.44 M(+1622.3%) | $3.64 M(+1722.3%) |
| June 2005 | - | $200.00 K(>+9900.0%) | $200.00 K(>+9900.0%) |
| June 2005 | $200.00 K(+532.9%) | - | - |
| Mar 2005 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2004 | - | $0.00(0.0%) | -$5000.00(0.0%) |
| Sept 2004 | - | $0.00(0.0%) | -$5000.00(-115.8%) |
| June 2004 | $31.60 K(-48.3%) | $0.00(-100.0%) | $31.60 K(+58.8%) |
| Mar 2004 | - | -$5000.00(<-9900.0%) | $19.90 K(-73.0%) |
| Dec 2003 | - | $0.00(-100.0%) | $73.80 K(-25.9%) |
| Sept 2003 | - | $36.60 K(-412.8%) | $99.60 K(+63.3%) |
| June 2003 | $61.10 K(-88.6%) | -$11.70 K(-123.9%) | $61.00 K(-69.9%) |
| Mar 2003 | - | $48.90 K(+89.5%) | $202.80 K(-51.3%) |
| Dec 2002 | - | $25.80 K(-1390.0%) | $416.50 K(-5.4%) |
| Sept 2002 | - | -$2000.00(-101.5%) | $440.20 K(-18.1%) |
| June 2002 | $537.80 K | $130.10 K(-50.5%) | $537.80 K(+31.9%) |
| Mar 2002 | - | $262.60 K(+430.5%) | $407.70 K(+181.0%) |
| Dec 2001 | - | $49.50 K(-48.2%) | $145.10 K(+51.8%) |
| Sept 2001 | - | $95.60 K | $95.60 K |
FAQ
- What is China Pharma Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for China Pharma Holdings?
- What is China Pharma Holdings annual CFF year-on-year change?
- What is China Pharma Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for China Pharma Holdings?
- What is China Pharma Holdings quarterly CFF year-on-year change?
- What is China Pharma Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for China Pharma Holdings?
- What is China Pharma Holdings TTM CFF year-on-year change?
What is China Pharma Holdings annual cash flow from financing activities?
The current annual CFF of CPHI is $73.10 K
What is the all time high annual CFF for China Pharma Holdings?
China Pharma Holdings all-time high annual cash flow from financing activities is $12.32 M
What is China Pharma Holdings annual CFF year-on-year change?
Over the past year, CPHI annual cash flow from financing activities has changed by +$1.84 M (+104.13%)
What is China Pharma Holdings quarterly cash flow from financing activities?
The current quarterly CFF of CPHI is $6800.00
What is the all time high quarterly CFF for China Pharma Holdings?
China Pharma Holdings all-time high quarterly cash flow from financing activities is $9.26 M
What is China Pharma Holdings quarterly CFF year-on-year change?
Over the past year, CPHI quarterly cash flow from financing activities has changed by +$483.20 K (+101.43%)
What is China Pharma Holdings TTM cash flow from financing activities?
The current TTM CFF of CPHI is $51.00 K
What is the all time high TTM CFF for China Pharma Holdings?
China Pharma Holdings all-time high TTM cash flow from financing activities is $12.93 M
What is China Pharma Holdings TTM CFF year-on-year change?
Over the past year, CPHI TTM cash flow from financing activities has changed by +$680.40 K (+108.10%)